about
Risk factors for liver-related mortality in chronic hepatitis C patients: a deceased case-living control study.Clinical Model for Predicting Hepatocellular Carcinomas in Patients with Post-Sustained Virologic Responses of Chronic Hepatitis C: A Case Control Study.HCV-specific interleukin-21+CD4+ T cells responses associated with viral control through the modulation of HCV-specific CD8+ T cells function in chronic hepatitis C patients.Myeloid-derived suppressor cells are associated with viral persistence and downregulation of TCR ζ chain expression on CD8(+) T cells in chronic hepatitis C patients.Generic ledipasvir-sofosbuvir for patients with chronic hepatitis C: A real-life observational study.Interferon-α plus ribavirin yields 98 % sustained virologic response in children aged 1-5 years with iatrogenic chronic hepatitis C.Letter: safety and efficacy of sofosbuvir plus daclatasvir with ribavirin for 12 weeks in Chinese treatment-experienced cirrhotic genotype 1b patients with HCV.Prevalence of Hepatitis C Virus and Hepatitis B Virus Infections in Patients Infected with HIV Through Blood Donation or Transfusion in China.Upregulation of OX40 ligand on monocytes contributes to early virological control in patients with chronic hepatitis C.Age versus clinical virological characteristics in chronic hepatitis B virus infection: a case series study in China.Prophylactic antiviral therapy for the prevention of mother-to-child transmission of hepatitis B virus can be stopped at delivery.Unexpected high incidence of hepatocellular carcinoma in patients with hepatitis C in the era of DAAs: Too alarming?[Fluctuating characteristics of HBsAg quantification and immune system in patients with chronic hepatitis B]Clinical course and treatment efficacy of COVID-19 near Hubei Province, China: a multicentre, retrospective study
P50
Q33594968-22F7FB3F-F9C0-4E09-8B39-D1923DE180A9Q37381785-66830649-64E9-4FC1-9276-94C2A17D5A50Q37462730-814557BE-F7E1-4D84-8AB6-DDA62E2CB4B8Q37532685-ED073EFB-C40B-4B04-B512-97867E4D781FQ38965560-D91D8946-BF2C-40FE-9673-F66303AD171EQ40961029-6DCE089D-9D55-4E33-A380-E95F2E7984F9Q42988802-8850D281-F191-4E3E-9EF5-4C801E6837ABQ45341420-DF776E67-B659-4EBC-8D42-92165E7FB641Q45346306-DD90F013-A762-4173-BF5B-A7339681CE18Q45360181-3AFE8D55-70EA-4BAF-BD4D-7EEC4BE908A9Q47560962-B5A11640-60AC-4592-87F0-2C4B992D938DQ54507981-052D8ABB-8B0F-4F36-8353-EB457E3096B5Q86051067-D8F616A2-9E3C-4FE1-9172-461CA7FE1F7EQ96342542-11B2C9FE-C7C7-4F83-A4F9-1A066F90432D
P50
description
investigador
@es
researcher
@en
name
Qing-Lei Zeng
@en
type
label
Qing-Lei Zeng
@en
prefLabel
Qing-Lei Zeng
@en
P31
P496
0000-0002-2094-4784